medicines which have been substrates of the CYP3A enzyme as they may turn out to be much less efficient throughout treatment with JOURNAVX. Your Health care company may have to adjust the dose of your medication when starting or halting JOURNAVXImportantly, these receptors have been discovered to are already activated by a wide range of endogenous